Large-scale pharmacogenomic studies and drug response prediction for personalized cancer medicine
Open Access
- 1 July 2021
- journal article
- review article
- Published by Elsevier in Journal of Genetics and Genomics
- Vol. 48 (7) , 540-551
Abstract
No abstract availableKeywords
Funding Information
- National Key Research and Development Program of China (2019YFC1315804)
- National Natural Science Foundation of China (31771472)
- Chinese Academy of Sciences (KFJ-STS-QYZD-126, ZDBS-SSW-DQC-02)
- Science and Technology Commission of Shanghai Municipality (2018SHZDZX01)
- Youth Innovation Promotion Association of the Chinese Academy of Sciences (2018307)
This publication has 96 references indexed in Scilit:
- Modeling precision treatment of breast cancerGenome Biology, 2013
- Genomics of Drug Sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cellsNucleic Acids Research, 2012
- The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics DataCancer Discovery, 2012
- Novel cancer immunotherapy agents with survival benefit: recent successes and next stepsNature Reviews Cancer, 2011
- Subtype and pathway specific responses to anticancer compounds in breast cancerProceedings of the National Academy of Sciences, 2011
- Molecular Target Class Is Predictive of In vitro Response ProfileCancer Research, 2010
- Are animal models predictive for humans?Philosophy, Ethics, and Humanities in Medicine, 2009
- The NCI60 human tumour cell line anticancer drug screenNature Reviews Cancer, 2006
- The Connectivity Map: Using Gene-Expression Signatures to Connect Small Molecules, Genes, and DiseaseScience, 2006
- The mighty mouse: genetically engineered mouse models in cancer drug developmentNature Reviews Drug Discovery, 2006